Hagège A - Search Results

1

[Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case].

Menasché P, Hagège A, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP. Menasché P, et al. Among authors: hagege a. Arch Mal Coeur Vaiss. 2001 Mar;94(3):180-2. Arch Mal Coeur Vaiss. 2001. PMID: 11338251 French.

2

Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?

Pouzet B, Vilquin JT, Hagège AA, Scorsin M, Messas E, Fiszman M, Schwartz K, Menasché P. Pouzet B, et al. Among authors: hagege aa. Circulation. 2000 Nov 7;102(19 Suppl 3):III210-5. doi: 10.1161/01.cir.102.suppl_3.iii-210. Circulation. 2000. PMID: 11082389

3

Myoblast transplantation for heart failure.

Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP. Menasché P, et al. Among authors: hagege aa. Lancet. 2001 Jan 27;357(9252):279-80. doi: 10.1016/S0140-6736(00)03617-5. Lancet. 2001. PMID: 11214133

4

Factors affecting functional outcome after autologous skeletal myoblast transplantation.

Pouzet B, Vilquin JT, Hagège AA, Scorsin M, Messas E, Fiszman M, Schwartz K, Menasché P. Pouzet B, et al. Among authors: hagege aa. Ann Thorac Surg. 2001 Mar;71(3):844-50; discussion 850-1. doi: 10.1016/s0003-4975(00)01785-9. Ann Thorac Surg. 2001. PMID: 11269463

5

[Transplantation of autologous skeletal myoblasts in ischemic cardiac insufficiency].

Pouzet B, Hagège AA, Vilquin JT, Desnos M, Duboc D, Marolleau JP, Menashé P. Pouzet B, et al. Among authors: hagege aa. J Soc Biol. 2001;195(1):47-9. J Soc Biol. 2001. PMID: 11530499 Review. French.

6

Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?

Pouzet B, Ghostine S, Vilquin JT, Garcin I, Scorsin M, Hagège AA, Duboc D, Schwartz K, Menasché P. Pouzet B, et al. Among authors: hagege aa. Circulation. 2001 Sep 18;104(12 Suppl 1):I223-8. doi: 10.1161/hc37t1.094593. Circulation. 2001. PMID: 11568060

7

[Myoblast transplantation for heart failure: where are we heading?].

Menasché P, Hagège AA, Desnos M. Menasché P, et al. Among authors: hagege aa. Arch Mal Coeur Vaiss. 2005 Jun;98(6):649-54. Arch Mal Coeur Vaiss. 2005. PMID: 16007819 Review. French.

8

[Dynamic cardiomyoplasty: models of action and indications].

Hagège A, Desnos M, Guérot C. Hagège A, et al. Arch Mal Coeur Vaiss. 1996 Nov;89 Spec No 6:47-50. Arch Mal Coeur Vaiss. 1996. PMID: 9092427 Review. French.

9

[Cellular cardiomyoplasty: state of the art, evaluation, and future possibilities].

Hagège A, Scorsin M, Samuel JL, Rappaport L, Ménasché P. Hagège A, et al. Arch Mal Coeur Vaiss. 1998 Nov;91(11):1429-35. Arch Mal Coeur Vaiss. 1998. PMID: 9864614 French.

10

Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function.

Scorsin M, Hagège A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, Menasché P. Scorsin M, et al. Among authors: hagege a. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1169-75. doi: 10.1067/mtc.2000.104865. J Thorac Cardiovasc Surg. 2000. PMID: 10838534 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters